Literature DB >> 25858553

Epidemiology of Clostridium difficile infection: results of a hospital-based study in Krakow, Poland.

J Czepiel1, J Kędzierska2, G Biesiada1, M Birczyńska3, W Perucki4, P Nowak2, A Garlicki1.   

Abstract

Over the past two decades Clostridium difficile infection (CDI) has appeared as a major public health threat. We performed a retrospective study based on the records of patients hospitalized for CDI at the University Hospital in Krakow, Poland, between 2008 and 2014. In the study period, CDI occurred in 1009 individuals. There were 790 (78%) individuals who developed infection only once, whereas 219 (22%) developed infection more than once. The percentage of deaths within 14 days of CDI confirmation was 2·4%, with a mean age of 74·2 ± 15·9 years. Crude mortality was 12·9% in medical wards, 5·6% for surgical wards and 27·7% in the ICU setting. The time span between diagnosis and death was 5·1 days on average. Between 2008 and 2012 a 6·5-fold increase of CDI frequency with a posterior stabilization and even reduction in 2013 and 2014 was observed. According to the data analysed, 2/3 patients in our population developed CDI during their hospitalization even though they were admitted for different reasons. Medical wards pose a significantly higher risk of CDI than the surgical ones. Age is a risk factor for CDI recurrence. In the case of patients who died, death occurred shortly after diagnosis. The first CDI episode poses much higher risk of mortality than the consecutive ones.

Entities:  

Keywords:  Clostridium difficile; epidemiology; incidence rate; intensive care unit; mortality

Mesh:

Year:  2015        PMID: 25858553      PMCID: PMC9150945          DOI: 10.1017/S0950268815000552

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  48 in total

1.  Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China.

Authors:  Haihui Huang; Shi Wu; Minggui Wang; Yingyuan Zhang; Hong Fang; Ann-Chatrin Palmgren; Andrej Weintraub; Carl Erik Nord
Journal:  Clin Infect Dis       Date:  2008-12-15       Impact factor: 9.079

2.  Increasing rates in Clostridium difficile infection (CDI) among hospitalised patients, Spain 1999-2007.

Authors:  A Asensio; J Vaque-Rafart; F Calbo-Torrecillas; J J Gestal-Otero; F López-Fernández; A Trilla-Garcia; R Canton
Journal:  Euro Surveill       Date:  2008-07-31

3.  Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan.

Authors:  Yi-Chieh Lee; Jann-Tay Wang; An-Chi Chen; Wang-Huei Sheng; Shan-Chwen Chang; Yee-Chun Chen
Journal:  J Microbiol Immunol Infect       Date:  2011-12-29       Impact factor: 4.399

4.  Epidemiology and risk factors for Clostridium difficile infection in children.

Authors:  Thomas J Sandora; Monica Fung; Kathleen Flaherty; Laura Helsing; Patricia Scanlon; Gail Potter-Bynoe; Courtney A Gidengil; Grace M Lee
Journal:  Pediatr Infect Dis J       Date:  2011-07       Impact factor: 2.129

5.  Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains.

Authors:  Clotilde Rousseau; Isabelle Poilane; Loic De Pontual; Anne-Claire Maherault; Alban Le Monnier; Anne Collignon
Journal:  Clin Infect Dis       Date:  2012-07-25       Impact factor: 9.079

6.  Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.

Authors:  Haihui Huang; Shi Wu; Renjie Chen; Shaohua Xu; Hong Fang; Andrej Weintraub; Carl Erik Nord
Journal:  Anaerobe       Date:  2014-09-08       Impact factor: 3.331

7.  The acquisition and outcome of ICU-acquired Clostridium difficile infection in a single centre in the UK.

Authors:  Chin Wee Ang; Graham Heyes; Paul Morrison; Bryan Carr
Journal:  J Infect       Date:  2008-11-17       Impact factor: 6.072

8.  Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study.

Authors:  Reetta Huttunen; Risto Vuento; Jaana Syrjänen; Päivi Tissari; Janne Aittoniemi
Journal:  Int J Infect Dis       Date:  2012-05-07       Impact factor: 3.623

9.  First isolation of Clostridium difficile PCR-ribotype 027/toxinotype III in Poland.

Authors:  Hanna Pituch; Dennis Bakker; Ed Kuijper; Piotr Obuch-Woszczatyński; Dorota Wultańska; Grazyna Nurzyńska; Anna Bielec; Ewa Bar-Andziak; Mirosław Łuczak
Journal:  Pol J Microbiol       Date:  2008

10.  Effects of reducing beta-lactam antibiotic pressure on intestinal colonization of antibiotic-resistant gram-negative bacteria.

Authors:  Saskia Nijssen; Ad Fluit; David van de Vijver; Janetta Top; Rob Willems; Marc J M Bonten
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

View more
  4 in total

Review 1.  Economic burden and cost-effectiveness of therapies for Clostridiodes difficile infection: a narrative review.

Authors:  Akshita Gupta; Ashwin N Ananthakrishnan
Journal:  Therap Adv Gastroenterol       Date:  2021-05-30       Impact factor: 4.409

Review 2.  Risk Factors, Diagnosis, and Management of Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  Livio Enrico Del Vecchio; Marcello Fiorani; Ege Tohumcu; Stefano Bibbò; Serena Porcari; Maria Cristina Mele; Marco Pizzoferrato; Antonio Gasbarrini; Giovanni Cammarota; Gianluca Ianiro
Journal:  Microorganisms       Date:  2022-06-29

3.  Global burden of Clostridium difficile infections: a systematic review and meta-analysis.

Authors:  Evelyn Balsells; Ting Shi; Callum Leese; Iona Lyell; John Burrows; Camilla Wiuff; Harry Campbell; Moe H Kyaw; Harish Nair
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

4.  Mortality Following Clostridioides difficile Infection in Europe: A Retrospective Multicenter Case-Control Study.

Authors:  Jacek Czepiel; Marcela Krutova; Assaf Mizrahi; Nagham Khanafer; David A Enoch; Márta Patyi; Aleksander Deptuła; Antonella Agodi; Xavier Nuvials; Hanna Pituch; Małgorzata Wójcik-Bugajska; Iwona Filipczak-Bryniarska; Bartosz Brzozowski; Marcin Krzanowski; Katarzyna Konturek; Marcin Fedewicz; Mateusz Michalak; Lorra Monpierre; Philippe Vanhems; Theodore Gouliouris; Artur Jurczyszyn; Sarah Goldman-Mazur; Dorota Wultańska; Ed J Kuijper; Jan Skupień; Grażyna Biesiada; Aleksander Garlicki
Journal:  Antibiotics (Basel)       Date:  2021-03-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.